Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AD/PD 2021 | Tau protein and the neurovascular unit in AD

Silvia Fossati • 16 Mar 2021
AD/PD 2021
Alzheimer’s Disease

Silvia Fossati, PhD, Temple University, Philadelphia, PA, discusses recent trends in the study of tau protein and its impact on Alzheimer’s disease (AD) pathology. The effect of tau protein on the neurovascular unit and its role in cerebrovascular pathology is receiving increasing attention, as is the intercellular movement of tau. It is hoped that these growing avenues of research could lead to an improved understanding of AD pathology in the future. This interview took place during the AD/PD™ 2021 conference.

More from Silvia Fossati

2:50
Highlights from AD/PD: advances in AD research
Silvia Fossati • 16 Mar 2021
6:29
Microvascular endothelial cell dysfunction in AD & CAA
Silvia Fossati • 16 Mar 2021

Related Videos

10:24
Comparing cognitive profiles in multiple sclerosis vs. Alzheimer's disease
Laura Hancock et al. • 22 Mar 2024
5:46
The impact of hypertension on neurovascular function in neurodegenerative diseases
Costantino Iadecola • 6 Feb 2024
3:26
Should endovascular thrombectomy be used in patients with pre-morbid dementia?
Aravind Ganesh • 20 Feb 2024
5:09
Defining the neurovasculome: advances in brain health research
Costantino Iadecola • 6 Feb 2024
The content of VJNeurology is intended for healthcare professionals